WOLMAN DISEASE

 

WOLMAN DISEASE

 

DEFINITION:

A lysosomal storage disorder characterized by the accumulation of lipids (cholesterol and triglycerides) primarily in peripheral tissues resulting in 2 clinical variants.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • infancy (first weeks of life)
  • risk factors:
    • familial - autosomal recessive
      • chrom. #: 10q24-q25
      • gene: acid lipase-A isoenzyme
    • M = F

PATHOGENESIS:

1. Background

  • acid lipase-A isoenzyme is a lysosomal hydrolase which acts upon cholesteryl esters in various lipoproteins under acid conditions
  • first reported by Wolman and associates in 1956

2. Genetic Defect

  • genetic defect -> deficiency of acid lipase-A isoenzyme activity -> accumulation of cholesterol (esterified form) and triglycerides in most tissues in the body, but in particular the liver, adrenals, and intestines
  • the central nervous system (CNS) is also involved but to a lesser extent
  • two clinical variants:

    1. Wolman Disease

    • acute infantile form
    • severe & fatal before age 1 year (usually by 6 months)

    2. Cholesteryl Ester Storage Disease - mild form

CLINICAL FEATURES:

1. Classical

  • hepatomegaly/hepatosplenomegaly
  • malabsorption with steatorrhea
  • enlarged and calcified adrenals

2. Additional Gastrointestinal Manifestations

  • abdominal distension
  • diarrhea
  • failure to thrive (FTT)
  • jaundice
  • vomiting - persistent and forceful

3. Others

  • progressive mental deterioration
  • anemia

4. Diagnosis

  • the presence of bilateral adrenal calcification associated with hepatosplenomegaly, malabsorption, and failure to thrive in an infant

INVESTIGATIONS:

1. Diagnostic

  • deficiency of acid lipase-A isoenzyme activity in leukocytes or cultured skin fibroblasts
  • prenatal:
    • deficiency of acid lipase-A isoenzyme activity in cultured chorionic villi or amniocytes

2. Imaging Studies

1. CT

  • adrenal enlargement and calcification (present at birth)
  • calcification of the adrenals is pathognomonic
  • hepatosplenomegaly

3. For Malabsorption

  • see "Malabsorptive Disorders"

4. Serum

  • abnormal liver function tests
  • conjugated hyperbilirubinemia

5. Pathology

  • 1. Liver
    • foam cells, fibrosis, cirrhosis
    • lipid accumulation in Kupffer and parenchymal cells
  • 2. Adrenals
    • lipid accumulation and calcification
  • 3. Small bowel (SB)
    • lamina propria infiltrated with foam cells; most marked in the proximal SB but distal SB & colon also affected
    • thick, flattened, yellow villi
    • foam cells (lipid-laden histiocytes) are also seen in bone marrow, spleen, lymphatics, thymus, tonsils, thyroid, testes, ovaries, brain, lungs, and heart
  • MANAGEMENT:

    1. Lovstatin

    • HMG-CoA reductase inhibitor
    • suppresses cholesterol synthesis and apolipoprotein B production with signficant reductions in plasma cholesterol,triglycerides, and LDL cholesterol
    • may decrease degree of hepatosplenomegaly & adrenal dysfunction
    • 20 mg po bid

     

    Pediatric Database - WOLMAN DISEASE

    Pediatric Organization - Pedbase [at] Gmail.com